Organic Volatile Impurities in Pharmaceutical Products: Selectivity of Capillary GC Columns

Importance of the Topic

Gas chromatography analysis of organic volatile impurities (OVIs) is critical in pharmaceutical manufacturing to ensure product safety and regulatory compliance. Residual solvents such as benzene, chloroform and others are toxic at trace levels and must be monitored according to USP <467> and European Pharmacopoeia guidelines.

Objectives and Study Overview

This study evaluates the selectivity of three capillary GC columns (SPB-5, OVI-G43 and SUPELCOWAX 10) for separating and quantifying five regulated OVIs plus additional residual solvents. The goal was to compare elution patterns and identify optimal columns for screening and confirmatory analysis.

Methodology and Instrumentation

• Gas chromatograph equipped with a flame ionization detector at 250 °C
• Column dimensions: 30 m × 0.53 mm ID with film thicknesses of 5.0 µm (SPB-5), 3.0 µm (OVI-G43) and 1.0 µm (SUPELCOWAX 10)
• Helium carrier gas at 35 cm/s initial flow, temperature program from 40 °C (5 min) to 200 °C at 2 °C/min
• Injection of 0.2 µL neat solvent mix, split ratio 100:1

Main Results and Discussion

• Elution order varied with stationary phase due to differences in dispersive, dipole, π–π and hydrogen-bonding interactions
• SPB-5 and OVI-G43 (polysiloxane phases) provided similar but not identical separations for 42 common solvents
• SUPELCOWAX 10 (polyethylene glycol phase) exhibited the greatest changes in elution order and resolution, offering complementary separation
• Combination of OVI-G43 and SUPELCOWAX 10 columns resolves all 42 solvents and enhances confirmatory analysis

Benefits and Practical Applications

This comparative assessment enables analysts to select the most appropriate column for routine OVI screening and residual solvent profiling in pharmaceutical products. The dual-column approach improves confidence in API quality control and compliance with USP and European monographs.

Future Trends and Applications

Advances in stationary phase chemistry and ultrafast GC methods are expected to shorten analysis times and increase throughput. Coupling with mass spectrometry and automated data processing will further enhance sensitivity and selectivity for trace impurity monitoring.

Conclusion

SPB-5 and OVI-G43 columns effectively separate USP-regulated OVIs, while SUPELCOWAX 10 offers unique selectivity for broader solvent profiling. A dual-column strategy combining polysiloxane and polyethylene glycol phases ensures comprehensive separation and reliable quantitation of residual solvents.

References

• United States Pharmacopeia, USP <467> Organic Volatile Impurities, USP 23–NF18, The National Formulary, 1995, p. 1746–1748